Literature DB >> 16140415

Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

Ayako Suzuki1, Keith Lindor, Jenny St Saver, James Lymp, Flavia Mendes, Ayako Muto, Toshihide Okada, Paul Angulo.   

Abstract

BACKGROUND/AIMS: The effects of lifestyle modifications in nonalcoholic fatty liver disease (NAFLD) are incompletely defined. We aimed at determining the association of changes in body weight and lifestyle with changes in serum ALT levels.
METHODS: We analyzed annual health checkup data from 1546 employees. Of 469 subjects with elevated ALT, we selected 348 male subjects by excluding those who had other causes of liver disease. They were followed for one year to assess the association of change in lifestyle with change in serum ALT. The 136 subjects who had ALT normalization were followed for two years to assess the association between lifestyle management and persistently normal ALT.
RESULTS: In adjusted analysis, weight loss and regular exercise were significantly associated with improvement in serum ALT and increased the odds of ALT normalization, while starting smoking was significantly associated with deterioration in serum ALT. Subjects achieving > or = 5% weight reduction showed improvement in serum ALT. Reduction in alcohol consumption was not associated with changes in serum ALT. Maintaining reduced weight (<5% gain) was significantly associated with persistently normal ALT.
CONCLUSIONS: Reducing weight by at least 5% with subsequent weight control and exercising regularly may be beneficial in treating NAFLD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140415     DOI: 10.1016/j.jhep.2005.06.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  78 in total

1.  Transaminase levels and vigorous exercise.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-12

2.  Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption.

Authors:  Jaimie N Davis; Kim-Anne Lê; Ryan W Walker; Susanna Vikman; Donna Spruijt-Metz; Marc J Weigensberg; Hooman Allayee; Michael I Goran
Journal:  Am J Clin Nutr       Date:  2010-10-20       Impact factor: 7.045

3.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

4.  Current status of therapy in nonalcoholic Fatty liver disease.

Authors:  Scott McNear; Stephen A Harrison
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

Review 5.  Benefits of lifestyle modification in NAFLD.

Authors:  Stephen A Harrison; Christopher Paul Day
Journal:  Gut       Date:  2007-10-02       Impact factor: 23.059

6.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

7.  SCAP gene polymorphisms decrease the risk of nonalcoholic fatty liver disease in females with metabolic syndrome.

Authors:  Shanshan Sun; Miao Wang; Haiyan Song; Tao Wu; Huafeng Wei; Songhua He; Zhaoguo Ding; Guang Ji
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

8.  Ethnic differences in the link between insulin resistance and elevated ALT.

Authors:  Mark D Deboer; R Constance Wiener; Barrett H Barnes; Matthew J Gurka
Journal:  Pediatrics       Date:  2013-08-12       Impact factor: 7.124

Review 9.  Non-alcoholic fatty liver disease: a diabetologist's perspective.

Authors:  Joseph M Pappachan; Farrah A Antonio; Mahamood Edavalath; Arjun Mukherjee
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

10.  Quantitative analysis of hepatic fat fraction by single-breath-holding MR spectroscopy with T₂ correction: phantom and clinical study with histologic assessment.

Authors:  Norio Hayashi; Tosiaki Miyati; Takashi Minami; Yumie Takeshita; Yasuji Ryu; Tsuyoshi Matsuda; Naoki Ohno; Takashi Hamaguchi; Kenichiro Kato; Toshinari Takamura; Osamu Matsui
Journal:  Radiol Phys Technol       Date:  2012-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.